Drug Ad Bill Meets Defeat in Senate

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

NEW YORK The latest bid by Sen. John Edwards (D-N.C.) to limit prescription drug ads was dealt a fatal blow when it was voted down 59 to 39 in the U.S. Senate on Thursday.

The presidential contender has made direct-to-consumer ads for prescription drugs a focal point of his political campaign.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in